RGD Reference Report - Fibrinogen Seoul (FGG Ala341Asp): a novel mutation associated with hypodysfibrinogenemia. - Rat Genome Database

Send us a Message

Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

Fibrinogen Seoul (FGG Ala341Asp): a novel mutation associated with hypodysfibrinogenemia.

Authors: Song, KS  Park, NJ  Choi, JR  Doh, HJ  Chung, KH 
Citation: Song KS, etal., Clin Appl Thromb Hemost. 2006 Jul;12(3):338-43.
RGD ID: 11352675
Pubmed: (View Article at PubMed) PMID:16959688
DOI: Full-text: DOI:10.1177/1076029606291383

Dysfibrinogenemia is a coagulation disorder caused by a variety of structural abnormalities in the fibrinogen molecule that result in fibrinogen function. The molecular basis of hypodysfibrinogenemia was investigated in a 66-year-old woman with peripheral artery obstructive disease and in her family members. Plasma level of functional fibrinogen determined using the Clauss method was lower (75 mg/dL; normal, 140-460 mg/dL) than that measured with immunologic nephelometric assay (137 mg/dL; normal, 180-400 mg/dL). Similar results were also observed in two family members through two generations. DNA was extracted from whole blood, and the coding regions and intron/exon boundaries of gamma chain gene (FGG) were amplified. A novel (Fibrinogen Seoul) heterozygous FGG mutation (GCT->GAT, Ala341Asp) was identified in all three affected family members. Thrombin-catalyzed polymerization was found to be defective on the analysis of purified fibinogen from the propositus. Molecular modeling also showed a conformational change of fibrinogen structure.

Disease Annotations    

Objects Annotated

Genes (Rattus norvegicus)
Fgg  (fibrinogen gamma chain)

Genes (Mus musculus)
Fgg  (fibrinogen gamma chain)

Genes (Homo sapiens)
FGG  (fibrinogen gamma chain)

Additional Information